Skip to content

European approval recommended for hepatitis C drug boceprevir

Further cuts in drug prices make tenofovir more affordable for low-income countries

Janssen issues warning on potential non-toxic contamination of Prezista 400mg or 600mg tablets

New hepatitis C drugs pose many questions

HIV drug prescribing in London to change from this month

HIV drug prescribing in London to change from this month

Once-daily nevirapine approved in United States

Attachment inhibitor BMS-663068 potent and well-tolerated in early study

GSK and Pfizer HIV divisions to form new company

WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs